timolol has been researched along with Epistaxis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andorfer, KEC; Berneburg, M; Bohr, C; Fischer, R; Koller, M; Kühnel, TS; Seebauer, CT; Vielsmeier, V; Zeman, F | 1 |
| Albarki, H; Rimmer, J | 1 |
| Beaudoin, M; Bergerot, C; Bréant, V; Colombet, B; Decullier, E; Dupuis-Girod, S; Fargeton, AE; Faure, F; Letievant, JC; Philouze, P; Pitiot, V | 1 |
| Chakinala, MM; Kallogjeri, D; Lee, JJ; Peterson, AM; Piccirillo, JF; Schneider, JS | 1 |
| Brilliant, MH; Epperla, N; Vidaillet, H | 1 |
| Dias, MS; Ichimura, K; Imayoshi, S; Kikuchi, H | 1 |
1 review(s) available for timolol and Epistaxis
| Article | Year |
|---|---|
The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Topics: Epistaxis; Humans; Propranolol; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Telangiectasia, Hereditary Hemorrhagic; Timolol | 2022 |
3 trial(s) available for timolol and Epistaxis
| Article | Year |
|---|---|
TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Topics: Cross-Over Studies; Epistaxis; Humans; Nasal Sprays; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Telangiectasia, Hereditary Hemorrhagic; Timolol | 2022 |
Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Epistaxis; Female; Humans; Male; Middle Aged; Nasal Sprays; Recurrence; Telangiectasia, Hereditary Hemorrhagic; Timolol; Treatment Outcome | 2019 |
Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Topics: Administration, Intranasal; Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Epistaxis; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Severity of Illness Index; Telangiectasia, Hereditary Hemorrhagic; Timolol; Treatment Outcome; Young Adult | 2020 |
2 other study(ies) available for timolol and Epistaxis
| Article | Year |
|---|---|
Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.
Topics: Administration, Intranasal; Adrenergic beta-Antagonists; Bradycardia; Cytochrome P-450 CYP2D6; Epistaxis; Humans; Male; Middle Aged; Ophthalmic Solutions; Telangiectasia, Hereditary Hemorrhagic; Timolol | 2014 |
Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Epistaxis; Female; Humans; Male; Middle Aged; Nasal Mucosa; Prospective Studies; Severity of Illness Index; Skin Transplantation; Telangiectasia, Hereditary Hemorrhagic; Timolol | 2016 |